2026年10月9日 7:15 ET 发布 · 更新于 1 个月前 · 1 个来源
Fidelity-Backed City Therapeutics Seeks $184.7 Million in US IPO
bloomberg
·
原始报道
City Therapeutics Inc., an early-stage developer of RNAi-based drugs, is seeking to raise as much as $184.7 million in a US initial public offering.
原文